Pro Medicus (PME.AX) Akcie Kurz
Pro Medicus Kurz
Tržby rostly o 17,3 % ročně za posledních 19 let na 261,69 Mil. AUD. Zisk na akcii rostl o 20,8 % ročně za posledních 19 let. čistá marže společnosti Pro Medicus je nyní 101,4 %, nahoru z 47,6 % před několika lety. Pro Medicus aktuálně nabízí dividendový výnos kolem 0,53 %. Výplatní poměr je kolem 73 % zisku. Dividenda rostla o 21,6 % ročně za posledních 19 let. Medián cílové ceny analytiků je 244,80 AUD, tedy nad aktuální cenu o 45,4 %. Z 17 analytiků jich 11 doporučuje nákup — celkový konsenzus je Koupit.
Cena akcie Pro Medicus
Obchodní model Pro Medicus a analýza akcií
Nejčastější otázky týkající se akcie Pro Medicus
The business model of Pro Medicus Ltd revolves around providing advanced healthcare imaging software solutions. The company specializes in developing and delivering a comprehensive range of radiology solutions that enhance workflow efficiency and improve patient care. Pro Medicus offers cutting-edge products like Visage AI, Visage 7, and Visage RIS, which allow healthcare professionals to efficiently manage and analyze medical images. By combining innovative technology with a customer-centric approach, Pro Medicus helps healthcare providers worldwide optimize their imaging operations and deliver accurate diagnoses. With its focus on developing state-of-the-art software solutions, Pro Medicus positions itself as a leader in the medical imaging industry.
Pro Medicus Ltd is primarily active in the healthcare industry.
The main competitors of Pro Medicus Ltd in the market include other medical imaging companies such as Carestream Health, Change Healthcare, and Sectra AB. These companies also specialize in providing medical imaging solutions and technology to healthcare providers and are prominent players in the industry. Pro Medicus Ltd competes with them in terms of product offerings, innovation, customer base, and market share.
Pro Medicus Ltd is a renowned healthcare imaging and information technology provider. Established in 1983, the company has a rich history of pioneering innovative solutions in the medical imaging industry. With a strong focus on radiology, Pro Medicus has developed advanced imaging software that improves efficiency and enhances patient care. The company's success is attributed to its commitment to research and development, resulting in cutting-edge technologies and multiple industry awards. Pro Medicus operates globally, serving prominent healthcare institutions and professionals. With its profound expertise and dedication to advancing medical imaging technology, Pro Medicus Ltd continues to lead the industry in providing innovative solutions for the healthcare sector.
Some significant milestones achieved by Pro Medicus Ltd include the successful expansion into major global markets, such as the United States and Europe, further solidifying its position as a leading provider of healthcare imaging solutions. The company has also experienced continuous revenue growth, achieving record-breaking financial results year after year. Pro Medicus Ltd has consistently developed and released innovative software solutions, enhancing efficiency and productivity for healthcare professionals. Additionally, the company has formed strategic partnerships with top-tier healthcare organizations, further establishing its reputation as a trusted industry leader. These accomplishments have propelled Pro Medicus Ltd's growth and success in the competitive healthcare technology sector.
Pro Medicus Ltd primarily operates in Australia and the United States.
Pro Medicus Ltd is a leading healthcare IT solutions provider with a strong commitment to excellence and innovation. The company's core values revolve around delivering exceptional products and services that empower healthcare professionals to enhance patient care and outcomes. Pro Medicus emphasizes a customer-centric approach and strives to provide customized solutions tailored to meet the unique needs of its clients. With a clear focus on technological advancements and high-quality imaging software, Pro Medicus constantly pushes the boundaries in the healthcare industry. By fostering a culture of collaboration and continuous improvement, Pro Medicus Ltd is dedicated to transforming the way medical images are managed and shared worldwide.
Analytici aktuálně stanovují průměrnou cílovou cenu 226,59 AUD pro akcii Pro Medicus (medián: 244,80 AUD), tedy +34,6 % vůči poslední ceně. Konsensus vychází z 17 hodnocení analytiků.
17 analytiků aktuálně hodnotí akcii Pro Medicus: 13 doporučuje koupit, 4 držet a 0 prodat.
Při aktuálním kurzu se akcie Pro Medicus obchoduje za 104,95 EUR (168,37 AUD).
Akcie Pro Medicus (PME.AX) je kótována na 3 burzách, mimo jiné: ASX (PME.AX), Frankfurt (PMC.F).
Pro Medicus Ltd is a global company specializing in providing advanced IT solutions for the healthcare industry. They offer innovative information and image management solutions that are used by leading healthcare organizations worldwide. Their main divisions include Picture Archiving and Communication Systems (PACS), Radiology Information Systems (RIS), and Telemedicine. Their PACS solutions allow hospitals and healthcare organizations to store, manage, and share digital images from medical diagnostic devices such as CT, MRI, and X-ray machines. These solutions are scalable and provide high-quality image quality for radiologists and other specialists to make informed diagnoses. Their RIS is an integrated solution designed specifically for radiology departments and practices, providing complete patient and order management, as well as integrated workflow tools to improve the efficiency and accuracy of diagnosing and evaluating medical imaging data. Their telemedicine solutions enable radiology professionals to edit and share medical images remotely over the internet, particularly beneficial in facilities with limited resources or for quick access to medical images in emergency diagnoses. In addition, Pro Medicus Ltd also offers specialized solutions for clinical decision support, automated medical image analysis, and patient management. Their clinical decision support provides assistance to medical professionals in diagnosis and treatment monitoring, while the automated analysis of medical image data allows for the quick processing of large amounts of data, producing results that can be utilized by professionals for diagnostic purposes. Their patient management solutions provide comprehensive capture and management of health data that can be used by doctors and other professionals to develop better treatment options for their patients. Pro Medicus Ltd is a global company with a strong focus on research and development. They have partnerships with leading healthcare organizations worldwide and possess a strong portfolio of intellectual property. Their business model is based on the sale of products and services specifically designed for the needs of the healthcare industry. The company emphasizes innovation, customer satisfaction, and delivering high-quality solutions that are scalable and flexible for various users. Overall, Pro Medicus Ltd is an innovative market leader in the field of medical IT solutions. They are globally recognized for their products and services and are expected to continue playing a significant role in the healthcare industry.
Tržby za Pro Medicus činí 261,69 Mil. AUD. Tato hodnota je založena na aktuálních finančních údajích a odráží výkonnost společnosti.
Zisk za Pro Medicus činí 265,34 Mil. AUD. Čistý zisk odráží ziskovost společnosti po odečtení všech nákladů.
Poměr ceny k zisku (P/E) Pro Medicus je aktuálně 66,40. Poměr P/E porovnává aktuální cenu akcie se ziskem na akcii a pomáhá investorům posoudit ocenění akcie Pro Medicus.
Poměr ceny k tržbám (P/S) Pro Medicus je aktuálně 67,32. Poměr P/S porovnává tržní kapitalizaci s ročními tržbami a slouží jako metrika ocenění akcie Pro Medicus.
Score kvality pro Pro Medicus je 8/10.
ISIN Pro Medicus je AU000000PME8. ISIN (International Securities Identification Number) je celosvětově jedinečný identifikátor cenných papírů.
WKN Pro Medicus je 591723. WKN (Wertpapierkennnummer) je šestimístný německý identifikační kód cenného papíru.
Ticker Pro Medicus je PME.AX. Symbol tickeru se používá k obchodování akcií Pro Medicus na burze.
Pro Medicus akcie
Pro Medicus Peer Group
Pro Medicus Ticker
Pro Medicus FIGI
Všechny fundamentální údaje o Pro Medicus v podrobné analýze
Naše analýzy akcií společnosti Pro Medicus zahrnují důležité finanční ukazatele jako obrat, zisk, P/E poměr, P/S poměr, EBIT, stejně jako informace o dividendách. Dále zkoumáme aspekty jako akcie, tržní kapitalizaci, dluhy, vlastní kapitál a závazky společnosti Pro Medicus. Pokud hledáte podrobnější informace o těchto tématech, nabízíme vám na našich podstránkách rozsáhlé analýzy: